LPTX: Leap Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Leap Therapeutics Inc (LPTX).
$110.16M Market Cap.
LPTX Market Cap. (MRY)
LPTX Shares Outstanding (MRY)
LPTX Assets (MRY)
Total Assets
$49.12M
Total Liabilities
$14.08M
Total Investments
$0
LPTX Income (MRY)
Revenue
$0
Net Income
-$67.56M
Operating Expense
$70.06M
LPTX Cash Flow (MRY)
CF Operations
-$60.30M
CF Investing
$0
CF Financing
$37.18M
LPTX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $49,124,000 (-32.55%) | $72,825,000 (3.51%) | $70,353,000 (-40.33%) | $117,911,000 (116.86%) |
Assets Current | $48,039,000 (-32.90%) | $71,597,000 (5.37%) | $67,950,000 (-41.86%) | $116,874,000 (123.58%) |
Assets Non-Current | $1,085,000 (-11.64%) | $1,228,000 (-48.90%) | $2,403,000 (131.73%) | $1,037,000 (-50.55%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $35,048,000 (-41.72%) | $60,141,000 (2.17%) | $58,866,000 (-45.44%) | $107,887,000 (131.26%) |
Property Plant & Equipment Net | $262,000 (0.00%) | $262,000 (-61.97%) | $689,000 (39.19%) | $495,000 (-16.53%) |
Cash & Equivalents | $48,072,000 (-32.87%) | $71,609,000 (7.51%) | $66,608,000 (-42.19%) | $115,209,000 (117.17%) |
Accumulated Other Comprehensive Income | -$120,000 (-213.21%) | $106,000 (-17.19%) | $128,000 (147.94%) | -$267,000 (53.89%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $704,000 (-8.69%) | $771,000 (-63.27%) | $2,099,000 (76.53%) | $1,189,000 (1528.77%) |
Trade & Non-Trade Payables | $4,743,000 (-26.64%) | $6,465,000 (14.28%) | $5,657,000 (35.04%) | $4,189,000 (54.18%) |
Accumulated Retained Earnings (Deficit) | -$467,371,000 (-16.96%) | -$399,582,000 (-25.59%) | -$318,168,000 (-20.71%) | -$263,572,000 (-18.20%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $159,000 (-11.17%) |
Tax Liabilities | $531,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $262,000 (608.11%) | $37,000 (-74.31%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $262,000 (608.11%) | $37,000 (-74.31%) |
Total Liabilities | $14,076,000 (10.97%) | $12,684,000 (10.42%) | $11,487,000 (14.59%) | $10,024,000 (29.84%) |
Liabilities Current | $14,076,000 (10.97%) | $12,684,000 (13.00%) | $11,225,000 (12.40%) | $9,987,000 (35.47%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $262,000 (608.11%) | $37,000 (-89.37%) |
LPTX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $1,500,000 (0.00%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $12,846,000 (-6.96%) | $13,807,000 (17.03%) | $11,798,000 (9.59%) | $10,766,000 (11.96%) |
Research & Development Expense | $57,211,000 (-21.88%) | $73,234,000 (62.87%) | $44,965,000 (39.82%) | $32,160,000 (57.47%) |
Operating Expenses | $70,057,000 (-19.51%) | $87,041,000 (53.34%) | $56,763,000 (32.23%) | $42,926,000 (42.90%) |
Interest Expense | $0 (0%) | $0 (0%) | $54,000 (31.71%) | $41,000 (5.13%) |
Income Tax Expense | $585,000 (0%) | $0 (0%) | $147,000 (712.50%) | -$24,000 (-1100.00%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$67,555,000 (17.02%) | -$81,414,000 (-49.12%) | -$54,596,000 (-34.52%) | -$40,587,000 (-47.51%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$67,555,000 (17.02%) | -$81,414,000 (-49.12%) | -$54,596,000 (-34.52%) | -$40,587,000 (-47.51%) |
Preferred Dividends Income Statement Impact | $234,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$67,789,000 (16.74%) | -$81,414,000 (-49.12%) | -$54,596,000 (-34.52%) | -$40,587,000 (-7.98%) |
Weighted Average Shares | $37,550,677 (83.67%) | $20,445,109 (80.55%) | $11,323,909 (31.94%) | $8,582,528 (44.66%) |
Weighted Average Shares Diluted | $37,550,677 (83.67%) | $20,445,109 (80.55%) | $11,323,909 (31.94%) | $8,582,528 (44.66%) |
Earning Before Interest & Taxes (EBIT) | -$66,970,000 (17.74%) | -$81,414,000 (-49.67%) | -$54,395,000 (-34.08%) | -$40,570,000 (-47.65%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $1,500,000 (0.00%) |
Operating Income | -$70,057,000 (19.51%) | -$87,041,000 (-53.34%) | -$56,763,000 (-37.02%) | -$41,426,000 (-45.16%) |
LPTX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $48,969,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $37,184,000 (124046.67%) | -$30,000 (85.71%) | -$210,000 (-100.21%) | $98,035,000 (32.49%) |
Net Cash Flow from Operations | -$60,299,000 (-37.82%) | -$43,753,000 (10.79%) | -$49,044,000 (-39.50%) | -$35,157,000 (-35.44%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$23,394,000 (-554.87%) | $5,143,000 (110.41%) | -$49,416,000 (-178.63%) | $62,845,000 (30.44%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $48,969,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $40,132,000 (4013300.00%) | -$1,000 (0%) | $0 (0%) | $98,219,000 (100.79%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$279,000 (-548.84%) | -$43,000 (73.46%) | -$162,000 (-390.91%) | -$33,000 (-128.70%) |
Share Based Compensation | $5,504,000 (7.33%) | $5,128,000 (-1.00%) | $5,180,000 (40.53%) | $3,686,000 (43.31%) |
Depreciation Amortization & Accretion | $5,000 (-66.67%) | $15,000 (-6.25%) | $16,000 (-44.83%) | $29,000 (-14.71%) |
LPTX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | 100.00% (0.00%) |
Profit Margin | - | - | - | -2705.80% (-7.98%) |
EBITDA Margin | - | - | - | -2702.70% (-47.73%) |
Return on Average Equity (ROAE) | -137.50% (-3.23%) | -133.20% (-89.47%) | -70.30% (-26.90%) | -55.40% (34.59%) |
Return on Average Assets (ROAA) | -106.90% (-17.60%) | -90.90% (-46.85%) | -61.90% (-25.81%) | -49.20% (30.80%) |
Return on Sales (ROS) | - | - | - | -2704.70% (-47.65%) |
Return on Invested Capital (ROIC) | 542.40% (-40.11%) | 905.70% (14.83%) | 788.70% (40.76%) | 560.30% (11.75%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.59 (-52.55%) | -1.04 (-10.98%) | -0.94 (86.39%) | -6.89 (-93.06%) |
Price to Sales Ratio (P/S) | - | - | - | 185.38 (108.31%) |
Price to Book Ratio (P/B) | 3.14 (78.38%) | 1.76 (132.76%) | 0.76 (-71.46%) | 2.65 (-7.82%) |
Debt to Equity Ratio (D/E) | 0.4 (90.52%) | 0.21 (8.21%) | 0.2 (109.68%) | 0.09 (-43.64%) |
Earnings Per Share (EPS) | -1.81 (54.52%) | -3.98 (17.08%) | -4.8 (-2.13%) | -4.7 (25.40%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0.17 (-30.83%) |
Free Cash Flow Per Share (FCFPS) | -1.61 (24.95%) | -2.14 (50.59%) | -4.33 (-5.74%) | -4.1 (6.29%) |
Book Value Per Share (BVPS) | 0.93 (-68.29%) | 2.94 (-43.40%) | 5.2 (-58.65%) | 12.57 (59.88%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.31 (-63.28%) | 3.56 (-42.67%) | 6.21 (-54.78%) | 13.74 (49.90%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0%) | 0 (0%) | 1 (125.00%) | -4 (-33.33%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.69 (-132.11%) | -0.3 (-146.94%) | 0.64 (116.09%) | -3.96 (-43.77%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0.02 (-35.71%) |
Current Ratio | 3.41 (-39.54%) | 5.64 (-6.74%) | 6.05 (-48.28%) | 11.7 (65.04%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$60,299,000 (-37.82%) | -$43,753,000 (10.79%) | -$49,044,000 (-39.50%) | -$35,157,000 (-35.57%) |
Enterprise Value (EV) | $46,475,954 (91.16%) | $24,312,641 (170.21%) | -$34,628,381 (-121.58%) | $160,466,791 (112.36%) |
Earnings Before Tax (EBT) | -$66,970,000 (17.74%) | -$81,414,000 (-49.52%) | -$54,449,000 (-34.07%) | -$40,611,000 (-47.59%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$66,965,000 (17.73%) | -$81,399,000 (-49.69%) | -$54,379,000 (-34.13%) | -$40,541,000 (-47.73%) |
Invested Capital | -$13,024,000 (-13.57%) | -$11,468,000 (-58.88%) | -$7,218,000 (0.41%) | -$7,248,000 (-22.68%) |
Working Capital | $33,963,000 (-42.35%) | $58,913,000 (3.86%) | $56,725,000 (-46.93%) | $106,887,000 (138.05%) |
Tangible Asset Value | $49,124,000 (-32.55%) | $72,825,000 (3.51%) | $70,353,000 (-40.33%) | $117,911,000 (116.86%) |
Market Capitalization | $110,163,954 (3.96%) | $105,968,641 (137.81%) | $44,559,619 (-84.43%) | $286,151,791 (113.18%) |
Average Equity | $49,290,500 (-19.37%) | $61,133,750 (-21.32%) | $77,703,500 (6.09%) | $73,242,250 (65.07%) |
Average Assets | $63,390,000 (-29.23%) | $89,568,750 (1.60%) | $88,155,500 (6.94%) | $82,434,500 (56.03%) |
Invested Capital Average | -$12,347,000 (-37.35%) | -$8,989,500 (-30.34%) | -$6,897,000 (4.75%) | -$7,241,000 (-32.12%) |
Shares | 38,317,897 (49.88%) | 25,565,414 (158.18%) | 9,902,138 (12.12%) | 8,831,845 (48.04%) |
